BridgeBio Pharma, Inc. (BBIO) › Shareholders' EquityBridgeBio Pharma, Inc. (BBIO) — Shareholders' EquityAnnual figures by period end, from SEC filings.2016-12-31: $14.89M2017-12-31: $85.85M2018-12-31: $314.88M2019-12-31: $408.45M2020-12-31: $57.91M2021-12-31: -$870.41M2022-12-31: -$1.25B2023-12-31: -$1.35B2024-12-31: -$1.47B2025-12-31: -$2.09B-$2.09B2016-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$2.09B—2026-02-24Balance as of period end2024-12-31-$1.47B—2026-02-24Balance as of period end2023-12-31-$1.35B—2025-02-20Balance as of period end2022-12-31-$1.25B—2024-02-22Balance as of period end2021-12-31-$870.41M-1603.1%2023-02-23Balance as of period end2020-12-31$57.91M-85.8%2022-02-25Balance as of period end2019-12-31$408.45M+29.7%2021-02-25Balance as of period end2018-12-31$314.88M+266.8%2020-03-03Balance as of period end2017-12-31$85.85M+476.6%2020-03-03Balance as of period end2016-12-31$14.89M—2020-03-03Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)